Cinnarizine + calcium dobesilate

CAY10410 is an analog of PGD2/PGJ2 with structural modifications intended to give it PPAR&gamma ligand activity and resistance to metabolism. 15-deoxy-.

CAY10410 is an analog of PGD2/PGJ2 with structural modifications intended to give it PPAR&gamma ligand activity and resistance to metabolism. 15-deoxy-.

CAY10410 is an analog of PGD2/PGJ2 with structural modifications intended to give it PPAR&gamma ligand activity and resistance to metabolism. 15-deoxy-.

CAY10499 is a potent inhibitor of human HSL exhibiting an IC50 of 90 nM for the recombinant enzyme. The in vivo pharmacological efficacy of CAY10499 has not been reported.

CAY10499 is a potent inhibitor of human HSL exhibiting an IC50 of 90 nM for the recombinant enzyme. The in vivo pharmacological efficacy of CAY10499 has not been reported.

CAY10499 is a potent inhibitor of human HSL exhibiting an IC50 of 90 nM for the recombinant enzyme. The in vivo pharmacological efficacy of CAY10499 has not been reported.

CAY10499 is a potent inhibitor of human HSL exhibiting an IC50 of 90 nM for the recombinant enzyme. The in vivo pharmacological efficacy of CAY10499 has not been reported.

Biochem/physiol Actions CAY10566 is a potent and selective stearoyl-CoA desaturase 1 (SCD1) inhibitor (IC50 = 26 nM/hSCD1 and 4.5 nM/mSCD1: IC50 &gt:10 &#956:M/75 receptors, transporters, ion channels).

Biochem/physiol Actions CAY10566 is a potent and selective stearoyl-CoA desaturase 1 (SCD1) inhibitor (IC50 = 26 nM/hSCD1 and 4.5 nM/mSCD1: IC50 &gt:10 &#956:M/75 receptors, transporters, ion channels).

A dual inhibitor of mPGES-1 (IC₅₀= 1.3 &muM) and 5-LO (IC₅₀ = 1.0 &muM) effectively inhibits PGE2 and LT synthesis in both cell free and intact cell assays.

A potent, reversible inhibitor of 5-LO, in cell-free assays (IC₅₀ = 86 nM), intact neutrophils (IC₅₀ = 230 nM), and in whole blood (IC₅₀ = 830 nM) significantly reduces both LT biosynthesis and inflammatory

A potent, reversible inhibitor of 5-LO, in cell-free assays (IC₅₀ = 86 nM), intact neutrophils (IC₅₀ = 230 nM), and in whole blood (IC₅₀ = 830 nM) significantly reduces both LT biosynthesis and inflammatory